Will Fix Shortage, 5 More Firms To Make Anti-Black Fungus Drug: Centre

Coronavirus: "Black fungus (Mucormycosis) curing drug Amphotericin B's shortage will be resolved soon," Union Minister Mansukh Mandaviya tweeted

Five more companies in India have been allowed to make drugs to treat black fungus or mucormycosis, the government said today. Any shortage of medicines to treat the opportunistic fungal infection that's affecting some COVID-19 patients in several states will be resolved soon, Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya tweeted today. Black Fungus (Mucormycosis) curing drug #AmphotericinB 's shortage will be resolved soon!Within three days, 5 more Pharma companies have got New Drug Approval for producing it in India, in addition to the existing 6 pharma companies. (1/2) pic.twitter.com/hm9KiZgxr4 "Black fungus (mucormycosis) curing drug Amphotericin B's shortage will be resolved soon! Within three days, 5 more Pharma companies have got New Drug Approval for producing it in India, in addition to the existing 6 pharma companies," Mr Mandaviya tweeted. "The existing pharma companies have already started ramping up the production.Indian Companies have also placed orders for importing 6 lakh vials of Amphotericin B. We are leaving no stone unturned to smoothen the situation," the minister tweeted.